{"transactions":[{"id":1686819,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:30:10.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028."}],"balance_after":150000,"derivative":{"exercise_price":4.64,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-001907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017024001907/ownership.xml","form_type":"4"}},{"id":2058289,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-10T02:36:28.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":115900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027."}],"balance_after":115900,"derivative":{"exercise_price":2.05,"expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":115900},"source":{"system":"sec-edgar","filing":"0000899243-23-001409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924323001409/doc4.xml","form_type":"4"}},{"id":2434577,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-14T22:58:50.000Z","date":"2022-01-12","kind":"exercise","acquired":false,"shares":15532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024."}],"balance_after":83631,"derivative":{"exercise_price":4.77,"expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":15532},"source":{"system":"sec-edgar","filing":"0000899243-22-002027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002027/doc4.xml","form_type":"4"}},{"id":2434576,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-14T22:58:50.000Z","date":"2022-01-12","kind":"exercise","acquired":false,"shares":24199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024."}],"balance_after":36937,"derivative":{"exercise_price":1.56,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":24199},"source":{"system":"sec-edgar","filing":"0000899243-22-002027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002027/doc4.xml","form_type":"4"}},{"id":2434575,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-14T22:58:50.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":79516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026."}],"balance_after":79516,"derivative":{"exercise_price":11.55,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":79516},"source":{"system":"sec-edgar","filing":"0000899243-22-002027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002027/doc4.xml","form_type":"4"}},{"id":2434574,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:58:50.000Z","date":"2022-01-12","kind":"exercise","acquired":true,"shares":15532,"price":4.77,"value":74087.64,"ownership":{"direct":true},"balance_after":164888,"source":{"system":"sec-edgar","filing":"0000899243-22-002027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002027/doc4.xml","form_type":"4"}},{"id":2434573,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:58:50.000Z","date":"2022-01-12","kind":"exercise","acquired":true,"shares":24199,"price":1.56,"value":37750.44,"ownership":{"direct":true},"balance_after":149356,"source":{"system":"sec-edgar","filing":"0000899243-22-002027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002027/doc4.xml","form_type":"4"}},{"id":2729224,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T20:31:19.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":57908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025."}],"balance_after":57908,"derivative":{"exercise_price":16,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":57908},"source":{"system":"sec-edgar","filing":"0000899243-21-018112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321018112/doc4.xml","form_type":"4"}},{"id":2729223,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":95454,"kind":"person","name":"Seidel-Dugan Cynthia","position":1,"cik":"0001857799","reported_name":"Seidel-Dugan Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T20:31:19.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":99163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024."}],"balance_after":99163,"derivative":{"exercise_price":4.77,"expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":99163},"source":{"system":"sec-edgar","filing":"0000899243-21-018112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321018112/doc4.xml","form_type":"4"}}]}